Etoposide
Application Notes
Etoposide inhibits DNA synthesis and is very active against cells in the late S and G2 phases of the cell cycle. Etoposide was reported to be used to serum starve Saos-2 M5(p53−/−) cells which were transfected by electroporation with indicated expression plasmids for flag-E2F1 and myc-EBNA3C for selection of colony forming units, thus studying the blocking effect of EBV Nuclear Antigen 3C on E2F1 Mediated Apoptosis Induced by the DNA Damage Response.
Usage Statement
Unless specified otherwise, MP Biomedical's products are for research or further manufacturing use only, not for direct human use. For more information, please contact our customer service department.
Key Applications
Topoisomerase inhibitor
SKU | 02193918-CF |
Alternate Names | EPA; Demethyl-epiodophyllotoxin ethylidene glucoside; Vepesid; EPEG; VP-16; VP-16213; NK 171; NSC-141540; 4'-Demethylepipodophyllotoxin; 9-(4,6-O-Ethylidene-b-D-Glucopyranoside) |
Application Notes | Etoposide inhibits DNA synthesis and is very active against cells in the late S and G2 phases of the cell cycle. Etoposide was reported to be used to serum starve Saos-2 M5(p53−/−) cells which were transfected by electroporation with indicated expression plasmids for flag-E2F1 and myc-EBNA3C for selection of colony forming units, thus studying the blocking effect of EBV Nuclear Antigen 3C on E2F1 Mediated Apoptosis Induced by the DNA Damage Response. |
Base Catalog Number | 193918 |
Biochemical Physiological Actions | Etoposide is an antitumor agent that complexes with topoisomerase II and DNA to enhance double-strand and single-strand cleavage of DNA and reversibly inhibit religation. Blocks the cell cycle in in S-phase and G2-phase of the cell cycle; induces apoptosis in normal and tumor cell lines; inhibits synthesis of the oncoprotein Mdm2 and induces apoptosis in tumor lines that overexpress Mdm2. |
CAS # | 33419-42-0 |
EC Number | 251-509-1 |
Format | Powder |
Hazard Statements | H302-H350 |
Melting Point | 236-251 °C |
Molecular Formula | C29H32O13 |
Molecular Weight | 588.562 g/mol |
Personal Protective Equipment | Eyeshields, Full-face particle respirator, Gloves, Respirator cartridge, Respirator filter |
pKa | 9.8 (Lit.) |
RTECS Number | KC0190000 |
Safety Symbol | GHS07, GHS08 |
Solubility | <h5 class="minor-section-title">Water Solubility</h5>Sparingly soluble |
Storage | BIOCHEMICALS |
Usage Statement | Unless specified otherwise, MP Biomedical's products are for research or further manufacturing use only, not for direct human use. For more information, please contact our customer service department. |
UV Visible Absorbance | λmax (methanol) |
Vapor Pressure | 5.4X10-23 mm Hg at 25 deg C /Estimated/ |